• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克林霉素-维甲酸凝胶与单独使用克林霉素或维甲酸治疗寻常痤疮的疗效和安全性:一项随机、双盲、赋形剂对照研究。

Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.

作者信息

Jarratt Michael T, Brundage Tom

机构信息

DermResearch Inc., Austin, TX, USA.

出版信息

J Drugs Dermatol. 2012 Mar;11(3):318-26.

PMID:22395582
Abstract

BACKGROUND

Topical combination therapy containing a retinoid and an antimicrobial is an effective treatment for acne vulgaris.

OBJECTIVE

To evaluate the efficacy and safety of a new topical formulation containing clindamycin phosphate 1.2% and tretinoin 0.025% solubilized in an aqueous-based gel (CT gel).

METHODS

1,649 participants were randomized 2:2:2:1 to 12 weeks of double-blind treatment with CT gel, clindamycin, tretinoin, or vehicle gel administered once daily.

RESULTS

Significantly more participants achieved 2-grade or greater improvement on the Investigator's Static Global Assessment score with CT gel versus clindamycin, tretinoin, or vehicle gel. CT gel produced a significantly greater reduction in absolute number of total lesions versus all other treatment groups, in total and noninflammatory lesions versus clindamycin, and in total and inflammatory lesions versus tretinoin. Local tolerability was similar to that of tretinoin alone; signs and symptoms of irritation were most notable at week 2. There were no more adverse events with CT gel than with tretinoin gel.

CONCLUSION

CT gel is more effective than clindamycin or tretinoin monotherapy, with a safety and tolerability profile similar to that of tretinoin.

摘要

背景

含维甲酸和抗菌剂的局部联合疗法是寻常痤疮的有效治疗方法。

目的

评估一种新的局部制剂(1.2%磷酸克林霉素和0.025%维甲酸溶解于水基凝胶中制成的CT凝胶)的疗效和安全性。

方法

1649名参与者按2:2:2:1随机分组,接受为期12周的双盲治疗,分别使用CT凝胶、克林霉素、维甲酸或赋形剂凝胶,每日给药一次。

结果

与克林霉素、维甲酸或赋形剂凝胶相比,使用CT凝胶的参与者在研究者静态整体评估评分上达到2级或更高改善的人数显著更多。与所有其他治疗组相比,CT凝胶使总皮损绝对数显著减少,与克林霉素相比,总皮损和非炎性皮损显著减少,与维甲酸相比,总皮损和炎性皮损显著减少。局部耐受性与单独使用维甲酸相似;刺激的体征和症状在第2周最为明显。CT凝胶的不良事件不比维甲酸凝胶多。

结论

CT凝胶比克林霉素或维甲酸单药治疗更有效,安全性和耐受性与维甲酸相似。

相似文献

1
Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.克林霉素-维甲酸凝胶与单独使用克林霉素或维甲酸治疗寻常痤疮的疗效和安全性:一项随机、双盲、赋形剂对照研究。
J Drugs Dermatol. 2012 Mar;11(3):318-26.
2
Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.对用于寻常痤疮的1.2%克林霉素磷酸酯-0.025%维甲酸凝胶与4%过氧化苯甲酰洗剂联用的随机耐受性分析。
Cutis. 2010 Dec;86(6):310-8.
3
Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.1.2%磷酸克林霉素-3%过氧化苯甲酰固定剂量复方凝胶治疗寻常痤疮的安全性和有效性:一项3期、多中心、随机、双盲、活性药物对照和赋形剂对照研究
J Drugs Dermatol. 2011 Dec;10(12):1382-96.
4
A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.一项随机、双盲、安慰剂对照的试点研究,旨在评估1.2%克林霉素与0.025%维甲酸联合凝胶治疗酒渣鼻12周的疗效和安全性。
J Drugs Dermatol. 2012 Mar;11(3):333-9.
5
A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.一项IV期开放标签研究,评估盐酸米诺环素缓释片、一种外用抗生素/维甲酸制剂和过氧化苯甲酰三联组合疗法用于中度至重度寻常痤疮患者的情况。
J Drugs Dermatol. 2013 Jun 1;12(6):619-25.
6
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.磷酸克林霉素(1.2%)与低浓度过氧化苯甲酰(2.5%)水凝胶固定组合在中度或重度痤疮亚组中的疗效和耐受性
J Drugs Dermatol. 2009 Aug;8(8):736-43.
7
Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.两项针对2219名受试者的随机、双盲、对照试验,比较克林霉素/维甲酸水凝胶联合用药与单独使用每种药物及赋形剂治疗寻常痤疮的效果。
J Am Acad Dermatol. 2006 Jan;54(1):73-81. doi: 10.1016/j.jaad.2005.04.046. Epub 2005 Nov 28.
8
Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.固定配方的1.2%磷酸克林霉素与0.025%维甲酸凝胶制剂(Velac)及一种专利的0.025%维甲酸凝胶制剂(Aberela)对面部痤疮的局部治疗效果。
J Eur Acad Dermatol Venereol. 1998 Nov;11(3):227-33.
9
Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.西班牙裔人群中中度至重度寻常痤疮的治疗:1.2%克林霉素/2.5%过氧化苯甲酰凝胶疗效和耐受性的事后分析
J Drugs Dermatol. 2012 Apr;11(4):455-9.
10
Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.克林霉素磷酸酯 1.2%-过氧化苯甲酰 3.0%固定剂量组合凝胶治疗日本寻常痤疮患者的疗效和安全性及耐受性良好:一项 III 期、多中心、随机、单盲、阳性药物对照、平行分组研究。
Br J Dermatol. 2015 Feb;172(2):494-503. doi: 10.1111/bjd.13265. Epub 2015 Jan 7.

引用本文的文献

1
Plant Phenolics in the Prevention and Therapy of Acne: A Comprehensive Review.植物多酚在痤疮的预防和治疗中的作用:综述
Molecules. 2024 Sep 6;29(17):4234. doi: 10.3390/molecules29174234.
2
Impact of Topical Vehicles and Cutaneous Delivery Technologies on Patient Adherence and Treatment Outcomes in Acne and Rosacea.外用载体和皮肤给药技术对痤疮和玫瑰痤疮患者依从性及治疗效果的影响
J Clin Aesthet Dermatol. 2023 May;16(5):26-34.
3
Dermatology: how to manage acne in skin of colour.皮肤病学:如何治疗有色人种皮肤的痤疮。
Drugs Context. 2022 May 31;11. doi: 10.7573/dic.2021-10-9. eCollection 2022.